Skip to content
Open access

Disentangling maternal pregnancy and fetal-specific plasma signatures through integrated proteomics and site-specific N-glycoproteomics

Oct 2026 · bioRxiv · 0 citations · 65 references
Biology

TL;DR

It is found that the fetus and mother have distinct proteomes, N-glycoproteoforms and alternative complement regulation, and that pregnancy in women led to specific N-glycosylation changes on a select set of primarily HDL-associated and acute-phase proteins.

Abstract

During pregnancy, mother and fetus co-exist albeit as two physiologically distinct individuals, connected through the placenta and the umbilical cord. This connection allows for the exchange of vital substances, while individual blood homeostasis remains intact. We hypothesized that comparing maternal and cord plasma (N-glyco)proteomes would provide insights into the biological communication and unique physiological state of each individual. As comparing only matched maternal and umbilical cord blood plasma misses a crucial identifier in determining whether observed changes are related to infancy, pregnancy or both, we designed a triad study by adding a non-pregnant women control group. This allowed us to distinguish pregnancy-specific proteins and their potentially altered N-glycosylation from those in infancy. We found that the fetus and mother have distinct proteomes, N-glycoproteoforms and alternative complement regulation. Moreover, we observed that pregnancy in women led to specific N-glycosylation changes on a select set of primarily HDL-associated and acute-phase proteins. Lastly, our data provide evidence for an early fetal development of the humoral immune system as especially fetal IgM displayed distinctive N-glycosylation signatures.

Read PDF

Similar papers

Open access Sep 2026

Comparative metabolomics of paired maternal–cord samples identifies pathway-level divergence

During pregnancy, the maternal and fetal metabolomes are linked and can influence one another through factors such as maternal diet. However, there is a lack of understanding of baseline maternal and neonate metabolomic similarities and differences. To investigate whether, for typical dyads, maternal metabolomic profil...

Ashley Van Winckel, Mrinalini Gupta, Rachel A. Klein et al. · 0 citations
Sep 2026

Integrated proteomic characterization of maternal blood, umbilical cord blood and placental tissue in gestational diabetes mellitus.

Gestational diabetes mellitus (GDM) is associated with adverse maternal and neonatal outcomes, but molecular alterations across the maternal-placental-fetal interface remain incompletely defined. We applied data-independent acquisition mass spectrometry to matched maternal blood (MB), umbilical cord blood (UCB) and pla...

Xiu-Bin Jia, Qi Wu, Yao-Han Li et al. · 0 citations
Open access Sep 2026

Maternal Metabolic Profiles, Their Relationships with Progesterone and Pregnancy-Associated Glycoprotein (PAG), and Biomarker Potential During Early Pregnancy in Lactating Ewes

Simple Summary Early pregnancy is a critical period for reproductive efficiency in ewes, but the systemic changes associated with successful pregnancy establishment before conventional diagnosis remain incompletely understood. This study evaluated whether routine blood measurements could characterize these changes and...

Gökhan Uyanık, A. Gozer, Murat Abay et al. · 0 citations
Open access Sep 2026

Matrix-Resolved Profiling of the Prenatal Chemical Exposome Reveals Selective Placental Retention and Fetal Transfer

Chemical exposure during human development, especially in utero, can disrupt many biological processes and increase disease vulnerability. Assessing the chemical landscape across the maternal–fetal interface is challenging. Here we address this challenge by conducting an exposome-based analysis across a suite of integr...

M. Marquès, R. Gil-Solsona, Ana González-Ruiz et al. · 0 citations
Open access Oct 2026

Proteomic Profiling of Xenobiotic and Nutrient Transporters in Human Placenta of Different Gestational Ages

The placenta serves a critical role in nutrient uptake and waste elimination for the developing fetus. The placenta is also responsible for the uptake and/or exchange of xenobiotics, including medications, between the maternal and fetal bloodstreams. An estimated 40–80% of women take medications or drugs during pregnan...

Eric M. Weaver, A. Topletz-Erickson, Edward J. Kelly et al. · 0 citations
Open access Oct 2026

Multi-omic profiling defines subtype-specific extracellular vesicle signatures in early human pregnancy.

Early human pregnancy (11-15 weeks) is a critical period when placental dysfunction begins but remains clinically undetectable, preventing early intervention for pregnancy complications. This highlights a pressing need for circulating biomarkers that can signal the onset of a complication. Circulating extracellular ves...

Kobe A. Abney, Taylor Hollingsworth, Alexandra Schneider et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.